Ryvu

About:

Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.

Website: https://ryvu.com/

Twitter/X: ryvutx

Top Investors: European Investment Bank, BioNTech, Leukemia & Lymphoma Society, National Center for Research & Development, Medical Research Agency

Description:

Ryvu is a biopharmaceutical company developing small-molecule therapies that address the clinical limitations of current treatments in oncology.